Logotype for Reliance Global Group Inc

Reliance Global Group (EZRA) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Reliance Global Group Inc

Q1 2026 earnings summary

8 May, 2026

Executive summary

  • Focused on simplifying operations, strengthening the balance sheet, and establishing a framework for long-term growth, with an active execution phase and expansion into technology and life sciences through Scale51 and LifeSci Global Group.

  • Operates two segments: insurance/InsurTech platform for recurring revenue and strategic ventures (EZRA International, Scale51) for disciplined capital deployment in tech and life sciences.

  • Enhanced RELI Exchange platform and expanded direct-to-consumer reach with 5MinuteInsure.com, supporting organic growth and operational efficiency.

  • Strategic investments in post-quantum cybersecurity (Enquantum) and life sciences (LifeSci Global, Innervate Radiopharmaceuticals) using milestone-based, phased capital deployment.

  • Insurance platform provides stable cash flow, enabling selective investment in high-growth opportunities.

Financial highlights

  • Unrestricted cash increased to $2.3M from $1.3M sequentially; combined cash rose to $3.2M from $2.7M.

  • Working capital improved to $2.6M from $1.9M; stockholders' equity increased to $7.4M from $6.4M.

  • Commission income was $3.8M, down from $4.2M year-over-year due to divestitures, but retained businesses saw 11% organic revenue growth.

  • Net loss improved to $1.4M from $1.7M year-over-year, driven by lower operating and interest expenses.

  • Adjusted EBITDA was -$0.4M versus +$0.1M year-over-year, reflecting lower stock-based compensation add-backs.

Outlook and guidance

  • Plans to continue disciplined execution of the dual-segment model, broadening investment opportunities and advancing current holdings.

  • Expects further organic growth in insurance through technology enhancements and agent expansion.

  • Strategic ventures will focus on milestone-based capital deployment and selective acquisitions in tech and life sciences.

  • Management believes current liquidity and capital resources are sufficient for at least the next twelve months.

  • Reverse stock split aims to regain Nasdaq compliance; no assurance of sustained compliance.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more